Across the recent three months, 14 analysts have shared their insights on Corteva CTVA, expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 9 | 1 | 0 | 0 |
| Last 30D | 0 | 3 | 0 | 0 | 0 |
| 1M Ago | 2 | 2 | 1 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 3 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $70.14, with a high estimate of $74.00 and a low estimate of $64.00. This upward trend is evident, with the current average reflecting a 2.71% increase from the previous average price target of $68.29.
Investigating Analyst Ratings: An Elaborate Study
The standing of Corteva among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $72.00 |
| Kristen Owen | Oppenheimer | Raises | Outperform | $72.00 | $70.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $70.00 | $68.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $74.00 | $69.00 |
| Richard Garchitorena | Wells Fargo | Raises | Overweight | $73.00 | $67.00 |
| Benjamin Theurer | Barclays | Raises | Equal-Weight | $64.00 | $62.00 |
| Joshua Spector | UBS | Lowers | Buy | $73.00 | $74.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $68.00 | $69.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $68.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $69.00 | $70.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $69.00 | $66.00 |
| Richard Garchitorena | Wells Fargo | Raises | Overweight | $67.00 | $65.00 |
| Steve Byrne | B of A Securities | Raises | Buy | $69.00 | $67.00 |
| Arun Viswanathan | RBC Capital | Lowers | Outperform | $68.00 | $69.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Corteva. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Corteva compared to the broader market.
- Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.
Capture valuable insights into Corteva's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Corteva analyst ratings.
Unveiling the Story Behind Corteva
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Corteva's Economic Impact: An Analysis
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Decline in Revenue: Over the 3 months period, Corteva faced challenges, resulting in a decline of approximately -10.19% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Corteva's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -22.53%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Corteva's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -2.1%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -1.26%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: Corteva's debt-to-equity ratio is below the industry average. With a ratio of 0.23, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
What Are Analyst Ratings?
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
